Covid-19 treatment was stopped by the FDA and regulators the GlaxoSmithKline drug doesn’t seem to be effective against BA.2. Now what do we do about COVID as companies push employees back to their desks and in-person events?
https://www.wsj.com/articles/new-omicron-subvariant-prompts-fda-limits-on-use-of-glaxosmithklines-antibody-drug-11648249966
https://www.wsj.com/articles/new-omicron-subvariant-prompts-fda-limits-on-use-of-glaxosmithklines-antibody-drug-11648249966
Recent Comments